{"url_path":"/sec/nutx/8-k/2026-07-21/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive Agreement.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1479681/0001628280-26-049061-index.html","accession_number":"0001628280-26-049061","cik":"0001479681","ticker":"NUTX","issuer_name":"Nutex Health Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1479681/0001628280-26-049061-index.html","primary_entity_key":"0001479681","primary_entity_name":"Nutex Health Inc."},"word_count":326,"has_tables":true,"body_markdown":"Item 1.01 Entry into a Material Definitive Agreement.\n\nEffective June 30, 2026, Nutex Health Inc., a Delaware corporation (the “Company”), on July 15, 2026, entered into a First Amendment (the “Amendment”) to that certain Payment Dispute Resolution Services Agreement, dated as of May 1, 2024 (the “Agreement”), by and between the Company and HaloMD, L.L.C., a Delaware limited liability company (“HaloMD”).\n\nThe services provided under the Agreement are subject to the regulatory framework established by the No Surprises Act, as implemented through the Federal Independent Dispute Resolution (IDR) process.\n\nThe Amendment, among other things, (i) transitions the fee payment structure to a pay-on-collected basis as opposed to payment due on award determination, retroactive to the Effective Date of the original Agreement, (ii) amends the service fee structure applicable to various federal and state net settlement amounts obtained on or after July 1, 2026, (iii) makes procedural amendments such as allowing HaloMD access to remittance data to confirm payment of awarded claims, (iv) provides the Company the right to perform dispute resolution services either in-house or through the engagement of another third-party vendor or service provider with respect to certain future hospital facilities, and (v) extends the initial term of the Agreement through December 31, 2029, subject to automatic one-year renewals.\n\nOn June 4, 2026, CMS and federal agencies reduced the non-refundable administrative fee for the Federal IDR process from $115 to $15 per party per dispute. This reduction took effect on June 11, 2026, to lower financial barriers for healthcare providers and payers.\n\nAs a result of the Amendment and the recently adopted new CMS Rules, the Company expects a reduction in our overall arbitration related costs.\n\n  \n\nSIGNATURE\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n \n\nDate: July 21, 2026\n\nNUTEX HEALTH INC. \n\n  \n\n  \n\n  \n\nBy: \n\n/s/ Jon C. Bates \n\n  \n\n  \n\nJon C. Bates \n\nChief Financial Officer"}